$62,22
▼ $-0,15
(-0,24%)
Vol. 2.4M
11
Punteggio di Qualità
ok
Analisi approfondita
2/5
ok
Ricavi ✓
Utile netto ✓
>IPO ✗
Cap. mercato
$25.9B
P/E
35,9
ROE
29,8%
Margine
16,0%
D/E
91,76
Beta
1,49
52W
$54–$93
Consenso Wall Street
37 analisti · Apr 202615
Acquisto forte
17
Compra
4
Mantieni
1
Vendi
0
Vendita forte
86,5%
Rating Compra
Grafico dei Prezzi
Titoli simili
Utili
Tasso di battuta: 50,0%| Trimestre | EPS Stimato | EPS Effettivo | Sorpresa |
|---|---|---|---|
| Dic 2025 | $0,66 | $0,45 | $-0,21 |
| Set 2025 | $0,58 | $0,61 | +$0,03 |
| Giu 2025 | $0,45 | $0,48 | +$0,03 |
| Mar 2025 | $0,33 | $0,32 | $-0,01 |
Ricavi e utili trimestrali
| Trimestre | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|
| Ricavi | $1.1B | $1.0B | $1.2B | $1.2B | $1.3B |
| Utile netto | $151.7M | $105.4M | $179.8M | $283.8M | $267.3M |
Trend fondamentali
| Metrica | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 25.6% | 25.6% | 25.6% | 29.8% | 29.8% | 29.8% |
| P/E (TTM) | 59.89 | 55.71 | 44.98 | 31.51 | 34.88 | 35.92 |
| Net Margin | 15.5% | 13.3% | 13.3% | 16.0% | 16.0% | 16.0% |
| Gross Margin | 59.5% | 60.0% | 60.0% | 60.2% | 60.2% | 60.2% |
| D/E Ratio | 97.21 | 97.21 | 97.21 | 91.76 | 91.76 | 91.76 |
| Current Ratio | 1.52 | 1.52 | 1.52 | 1.56 | 1.56 | 1.56 |
Rapporti chiave
ROA (TTM)
10,3%
P/S (TTM)
5,73
P/B
14,4
EPS (TTM)
$1,77
CF/Share
$1,28
Crescita ricavi 3A
+18,1%
52W High
$93,25
52W Low
$54,11
$54,11
Intervallo 52 settimane
$93,25
Salute finanziaria
Flusso di cassa libero
$192.1M
Debito netto
$472.0M
Liquidità
$917.7M
Debito totale
$1.4B
Aggiornato al Dic 31, 2025
Як DXCM виглядає на тлі конкурентів у Health Care?
Група порівняння: Micro-cap Health Care (All) · 241 компаній
Оцінка DXCM vs аналоги Health Care
P/E
35,9
▲
17%
sopra
peer
(30,7)
vs Peer
vs Settore
Sottovalutato
P/S
5,7
▲
122%
sopra
peer
(2,6)
vs Peer
vs Settore
Sopravvalutato
P/B
14,5
▲
420%
sopra
peer
(2,8)
vs Peer
vs Settore
Sopravvalutato
Дивідендна дохідність
—
▼
0%
sotto
peer
(0,7%)
vs Peer
vs Settore
Rendimento basso
Прибутковість DXCM vs аналоги Health Care
ROE
29,8%
▲
177%
sopra
peer
(-38,5%)
vs Peer
vs Settore
Top livello
Net margin
16,0%
▲
165%
sopra
peer
(-24,7%)
vs Peer
vs Settore
Top livello
Валова маржа
60,2%
▲
14%
sopra
peer
(52,9%)
vs Peer
vs Settore
In linea
ROA
10,3%
▲
148%
sopra
peer
(-21,2%)
vs Peer
vs Settore
Top livello
Фінансове здоровʼя DXCM vs аналоги Health Care
D/E ratio
91,8
▲
376%
sopra
peer
(19,3)
vs Peer
vs Settore
Debito alto
Поточна ліквідність
1,6
▼
28%
sotto
peer
(2,2)
vs Peer
vs Settore
Liquidità bassa
Beta
1,5
▲
42%
sopra
peer
(1,1)
vs Peer
vs Settore
Più volatile
Радар фундаменталів DXCM
DXCM
Mediana peer
Industria
DXCM прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
DXCM vs аналоги: ключові метрики
Segnali Correlati
Ultima opinione AI
Grok
BUY
Price action shows a recent dip from $73.78 on 2026-03-02 to $65.94 last week and now $63.32 near the session low of $63.27, presenting a potential good entry point on this pullback within the broader recovery from November 2025 lows …
Mar 27, 2026Attività insider
NeutralAcquisti
0
Vendite
0
BROWN MICHAEL JON
Officer · Mar 16
1700 shs
COLEMAN JON
Officer · Mar 06
43897 shs
SYLVAIN JEREME M
Chief Financial Officer · Mar 06
48774 shs
LEACH JACOB STEVEN
Chief Executive Officer · Mar 06
104516 shs
STERN SADIE
Officer · Mar 06
39019 shs
SAYER KEVIN R
Officer and Director · Mar 06
32749 shs
BROWN MICHAEL JON
Officer · Mar 06
39019 shs
HELLER BRIDGETTE P
Director · Feb 12
1012 shs
SYLVAIN JEREME M
Chief Financial Officer · Gen 29
7123 shs
LEACH JACOB STEVEN
Chief Executive Officer · Gen 29
8310 shs
Ultimo 90 giorni
Principali azionisti
Top 5: 34,7%Vanguard Group Inc
12,75%
$3.1B
Blackrock Inc.
10,35%
$2.5B
State Street Corporation
4,70%
$1.1B
BAILLIE GIFFORD & CO
4,04%
$968.1M
Geode Capital Management, L…
2,86%
$685.1M
Aggiornato al Dic 31, 2025
Ultime notizie
Nessuna notizia correlata ancora